Sat, Dec 27, 2014, 7:46 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

iShares Nasdaq Biotechnology Message Board

  • scanit2008 scanit2008 Mar 8, 2013 11:24 AM Flag

    Amarantus Bioscience - AMBS

    Currently trading under a dime.

    Considering the potential impact of the "Human Brain Mapping Project", the investment to date of approximately $35,000,000 in developing the patented MANF technology, and the value attached to Amarantus Diagnostics, and the fact that the GDNF technology sold for $265,000,000 I would attach a current value to Amarantus Bioscience in the $100,000,000 range or about .45/share.

    A joint venture or "big pharma" partnership announcement and the resulting short squeeze could take it much higher ($1.00?) but it would probably settle in the .45-.50 range.

306.61+6.81(+2.27%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
Tesla Motors, Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST